The Pune-based firm has started a VC fund, Persistent Venture Fund, which is an early-stage investment fund focusing on innovation in Social, Mobile, Analytics and Cloud (SMAC).
"We are in talks with several start-ups, and this quarter may invest is 2-3 firms, which could include one from India," Persistent Systems Chairman & CEO Anand Deshpande told PTI.
Also Read
Persistent reported a cash and cash equivalent of Rs 594 crore for the period ended December 31, 2013.
Deshpande, however, said talks take time and all the aspects, including financial viability and technological future will be considered before investing in start-ups.
"We are in initial stages (of talks) with some firms and in advanced with some others, so it is not necessary that the investment materialises during the quarter. The time period can extend. But, we do intend to keep up our effort," he said.
On the amount of investments, Deshpande said the maximum funding that the VC fund gives is USD 250,000.
He also said the firm is a strategic investor and not a financial one.
"We consider two aspects for selection. First is the technology area of the start-up and its similarity to our interests, and second the customers that it needs to align with our customer eco-system," he added.
Persistent Systems CFO Rohit Kamat said the company is usually looking at product development start-ups in the US as the eco-system is very advanced in that country and venture funds do not face problems in investing.
"Ours is a kind of seed fund. We do not participate in the management. In India, we do face some problems in terms of the management bandwidth and the firm's ability in the future to adapt to the technology challenges vis-a-vis the market," he added.
In the December quarter, the VC fund invested in two US companies Ustyme and DxNow.
In Ustyme, Persistent invested USD 250,000, while in DxNow, it has so far infused USD 125,000 and can further invest a similar amount in the near future.
Ustyme is a free video-call app for iPad that creates shared experiences through quality content like books and games, while, DxNow is a life sciences firm that uses advanced microfluidic and imaging technologies for point-of-care diagnostic solutions.
Persistent reported a 30% rise in consolidated net profit at Rs 64.20 crore for the quarter ended December 31, 2013, against Rs 49.51 crore in the year-ago period.
Its revenues rose 30% to Rs 432.76 crore from Rs 332.99 crore during the quarter under review.
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
